CytoSorbents Corp. (CTSO)
0.36
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 14:05
CytoSorbents EPS Diluted (Quarterly) : -0.0703 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0703 |
| March 31, 2026 | -0.0818 |
| December 31, 2025 | -0.0875 |
| September 30, 2025 | -0.0505 |
| June 30, 2025 | 0.029 |
| March 31, 2025 | -0.0243 |
| December 31, 2024 | -0.1441 |
| September 30, 2024 | -0.0508 |
| June 30, 2024 | -0.0791 |
| March 31, 2024 | -0.1118 |
| December 31, 2023 | -0.1318 |
| September 30, 2023 | -0.2072 |
| June 30, 2023 | -0.1398 |
| March 31, 2023 | -0.1677 |
| December 31, 2022 | -0.0176 |
| September 30, 2022 | -0.2798 |
| June 30, 2022 | -0.2498 |
| March 31, 2022 | -0.2062 |
| December 31, 2021 | -0.2141 |
| September 30, 2021 | -0.1476 |
| June 30, 2021 | -0.108 |
| March 31, 2021 | -0.0964 |
| December 31, 2020 | -0.0157 |
| September 30, 2020 | -0.0202 |
| June 30, 2020 | -0.0786 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1016 |
| December 31, 2019 | -0.1211 |
| September 30, 2019 | -0.2127 |
| June 30, 2019 | -0.1099 |
| March 31, 2019 | -0.153 |
| December 31, 2018 | -0.17 |
| September 30, 2018 | -0.096 |
| June 30, 2018 | -0.19 |
| March 31, 2018 | -0.1016 |
| December 31, 2017 | -0.1086 |
| September 30, 2017 | -0.07 |
| June 30, 2017 | -0.06 |
| March 31, 2017 | -0.06 |
| December 31, 2016 | -0.19 |
| September 30, 2016 | -0.09 |
| June 30, 2016 | -0.12 |
| March 31, 2016 | -0.08 |
| December 31, 2015 | -0.08 |
| September 30, 2015 | -0.11 |
| June 30, 2015 | 0.05 |
| March 31, 2015 | -0.19 |
| December 31, 2014 | -0.4502 |
| September 30, 2014 | -0.25 |
| June 30, 2014 | -0.25 |
| March 31, 2014 | -0.25 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.417M |
| Revenue (Quarterly) | 9.633M |
| Total Expenses (Quarterly) | 14.05M |
| Enterprise Value | 47.90M |
| Gross Profit Margin (Quarterly) | 73.18% |
| Profit Margin (Quarterly) | -45.85% |
| Earnings Yield | -80.58% |
| Normalized Earnings Yield | -75.25 |